NCT04071379 - Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

April 6, 2021

Study Completion Date

December 16, 2021

Conditions

ImmunogenicitySafety

Interventions

BIOLOGICAL

Recombinant Hepatitis B + DTP-HB-Hib

1 dose of 0.5 ml Recombinant Hepatitis B + 3 dose of 0.5 ml of DTP-HB-Hib

BIOLOGICAL

Hep B + Pentabio (registered)

1 dose of 0.5 ml Recombinant Hepatitis B (registered) + 3 dose of 0.5 ml of Pentabio (registered)

Trial Locations (3)

Garuda Primary Health Centre, Bandung

Ibrahim Adjie Primary Health Centre, Bandung

Puter Primary Health Care, Bandung